Joseph Payne
Chief Executive Officer chez ARCTURUS THERAPEUTICS HOLDINGS INC.
Fortune : 50 M $ au 31/03/2024
Profil
Joseph E.
Payne was the founder of Arcturus Therapeutics, Inc. (founded in 2013) where he served as the Chief Executive Officer from 2013 to 2018.
He is also the founder of Arcturus Therapeutics Ltd.
(founded in 2013) where he currently holds the position of President, Chief Executive Officer & Director.
Mr. Payne's current job is as the President, Chief Executive Officer & Director at Arcturus Therapeutics Holdings, Inc. since 2013.
He has previously worked as an Independent Director at Vallon Pharmaceuticals, Inc. from 2018 to 2023.
Mr. Payne also held positions at Bristol Myers Squibb Co. as a Principal, DuPont Pharmaceuticals Co. as a Staff Scientist, Nitto Denko Corp.
as a Senior Manager from 2009 to 2013, and Merck Research Laboratories Massachusetts LLC as a Research Scientist.
He completed his undergraduate degree at Brigham Young University and his graduate degree at the University of Calgary.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/12/2023 | 1 480 097 ( 5,50% ) | 50 M $ | 31/03/2024 |
Postes actifs de Joseph Payne
| Sociétés | Poste | Début |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Chief Executive Officer | 01/03/2013 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Founder | 01/03/2013 |
Anciens postes connus de Joseph Payne
| Sociétés | Poste | Fin |
|---|---|---|
| GRI BIOPAR | Director/Board Member | 21/04/2023 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Chief Executive Officer | 01/02/2018 |
| NITTO DENKO CORPORATION | Corporate Officer/Principal | 01/02/2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | - |
Formation de Joseph Payne
| Brigham Young University | Undergraduate Degree |
| University of Calgary | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NITTO DENKO CORPORATION | Electronic Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
